911426-06-7

Basic information

• Product Name: Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-
• Synonyms: Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-;Benzenemethanamine, 3,5-dibromo-a-methyl-, (aR)-;5-dibroMo-a-Methyl-;BENZENEMETHANAMINE, 3,5-DIBROMO-ALPHA-METHYL-, (ALPHAR)-;(R)-1-(3,5-dibromophenyl)ethanamine
• CAS NO: 911426-06-7
• Molecular Formula: C8H9Br2N
• Molecular Weight: 278.974
• Mol File: 911426-06-7.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-(911426-06-7)
• EPA Substance Registry System: Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-(911426-06-7)

Safety Data

• Hazardous Substances Data: 911426-06-7(Hazardous Substances Data)

Usage

General Description

Benzenemethanamine, 3,5-dibromo-α-methyl-, (αR)-, also known as (R)-3,5-dibromo-α-methylbenzylamine, is a chemical compound with the molecular formula C8H9Br2N. It is a chiral compound, meaning it has two non-superimposable mirror image forms (enantiomers), and the (αR)-enantiomer specifically refers to the right-handed form. This chemical is commonly used in organic synthesis and pharmaceutical research, and it may have potential applications in the development of new drugs or therapeutic compounds. It is important to handle this chemical with caution, as it may pose health and environmental risks if not properly managed.

Upstream product

• 911426-27-2 (1RS)-1-[3,5-dibromophenyl]ethylamine 

Relevant articles and documents

Indanyl-piperazine compounds

A compound selected from those of formula (I): wherein: R3 represents a hydrogen atom, and R1 and R2 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, ?or R1 represents a hydrogen atom, and R2 and R3 together with the carbon atoms carrying them form a benzene, naphthalene or quinoline ring structure, each of the ring structures being optionally substituted, n represents 1 or 2, —X— represents a group selected from —(CH2)m—O-Ak-, —(CH2)m—NR4-Ak-, —(CO)—NR4-Ak- and —(CH2)m—NR4-(CO)—, ?m represents an integer between 1 and 6 inclusive, Ak represents an optionally substituted alkylene chain, and R4 represents a hydrogen atom or an alkyl group, Ar represents an aryl or heteroaryl group, its enantiomers, diasteroisomers, and addition salts thereof with a pharmaceutically acceptable acid. Medical products containing the same which are useful in the treatment of conditions requiring a serotonin reuptake inhibitor and/or NK1 antagonist.